Quimioterapia neoadyuvante con gemcitabina-cisplatino vs metotrexato-vinblastina-adriamicina-cisplatino en pacientes con carcinoma urotelial vesical llevados a cistectomía radical: metaanálisis

The available evidence comparing neoadjuvant regimes such as gemcitabine-cisplatin vs methotrexate-vinblastine-adriamycin-cisplatin is limited and lacks randomised studies. The evidence provides similar results with both cancer neoadjuvant chemotherapy regimens.